Anvita Gupta

prof_pic.jpg

I’m the founder of AINovo Biotech Inc., a startup using Generative AI and Protein Design to develop new drugs and diagnostics for cancer and infectious diseases.

I did my Masters and Undergrad in Computer Science at Stanford University (AI + Biocomputation Specializations). At Stanford, I worked on Generative AI for Synthetic Genomics and Proteomics in the Kundaje and Zou labs. As a Research Fellow at ETH Zurich, I worked on Recurrent Neural Networks for Drug Design with Prof. Gisbert Schneider. I began my research journey working on Intrinsically Disordered Proteins in the lab of Prof. Gil Alterovitz at Harvard Medical School. My research interests are creating AI systems to program biology - design proteins and DNA, reprogram cells, or modulate biomolecular interactions.

I also work to inspire young women in STEM through LITAS For Girls, an international nonprofit I began in 2014. Check out the LITAS For Girls website to learn more.

Videos

Selected Publications

  1. amp_figure.png
    A Novel AI-Designed Antimicrobial Peptide Synergistically Potentiates Aminoglycosides against Colistin-and Carbapenem-Resistant Acinetobacter baumannii
    Neena Capalash, Vipasha Thakur, Varsha Gupta, Prince Sharma, and Anvita Gupta
    bioRxiv, Nov 2023
  2. dna-editing.png
    Targeted optimization of regulatory DNA sequences with neural editing architectures
    Anvita Gupta, and Anshul Kundaje
    Long Talk, Intelligent Systems for Molecular Biology (ISMB), Jul 2019
  3. fbgan.png
    Feedback GAN for DNA optimizes protein functions
    Anvita Gupta, and James Zou
    Nature Machine Intelligence, Feb 2019
  4. MolInf
    lstm.png
    Generative recurrent networks for de novo drug design
    Anvita Gupta, Alex T Müller, Berend JH Huisman, Jens A Fuchs, Petra Schneider, and Gisbert Schneider
    Molecular informatics, Feb 2018

Blog Posts